Menaquinone 7

DB13075InvestigationalSmall molecule

Menaquinone 7 is under investigation in clinical trial NCT00402974 (The Effect of Vitamin K Supplementation on Osteocalcin Carboxylation in Healthy Children).

Mechanism: Pharmacologically active on Nuclear factor NF-kappa-B
Curator reviewed
Formula / weight: C₄₆H₆₄O₂ · 648.9992 g/mol (avg)
Also known as: Menaquinone-7

Resolves to

Compound

UNII8427BML8NYCAS2124-57-4ChEBI44245PubChem5287554

Clinical / RWD

RxNorm2001758

Structure

InChIKeyRAKQPZMEYJZGPI-LJWNYQGCSA-NSMILES

[H]\C(CC\C(C)=C(/[H])CC\C(C)=C(/[H])CC\C(C)=C(/[H])CC\C(C)=C(/[H])CC\C(C)=C(/[H])CC1=C(C)C(=O)C2=CC=CC=C2C1=O)=C(\C)CCC=C(C)C

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Drug interactionStructured to mechanism, not free text

6Clinical trialsPhase, status and sponsor resolved per trial

5Marketed productsAcross 1 country and 4 labellers

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Menaquinone 7, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account